Aljubran, A. H., Almuhaideb, A., Raef, H., Almehaidib, A., Badran, A. A., Elhassan, T., Alharbi, S., Elshenawy, M. A. (2025). Peptide receptor radionuclide therapy (Lu-177 PRRT) in neuroendocrine tumors (NET): Single institution experience over 15 years.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16343